Therefore, the disruption of the interaction between p53 and MDM2/MDMX in cancer cells overexpressing MDM2/MDMX could reactivate the wtp53-dependent tumor-suppressive activities in human cancer cells. This evidence concerns the gene TP53 and neoplasm.